Table 1.
Patient and tumour-related characteristics
| Characteristics | n (%) |
|---|---|
| Sex | |
| Male | 36 (90.0) |
| Female | 4 (10.0) |
| Age (mean ± SD) | 68.4 ± 8.5 |
| Location (total) | |
| Cervical | 5 |
| Proximal third | 11 |
| Middle third | 26 |
| Distal third | 13 |
| Gastro-oesophageal junction | 4 |
| cT | |
| cT3 | 27 (67.5) |
| cT4 | 13 (32.5) |
| Dose (Gy) | |
| 54 | 1 (2.5) |
| 59.6 | 2 (5.0) |
| 60 | 34 (85.0) |
| 61.2 | 1 (2.5) |
| 62.4 | 1 (2.5) |
| 64 | 1 (2.5) |
| Chemotherapy | |
| Cisplatin/5-FU | 29 (72.5) |
| Nedaplatin/5-FU | 9 (22.5) |
| Docetaxel/cisplatin/5-FU | 2 (5.0) |
5-FU 5-fluorouracil